logo
AAT Bioquest

Buccutite™ Rapid PE-iFluor® 594 Tandem Antibody Labeling Kit *Microscale Optimized for Labeling 100 ug Antibody Per Reaction*

Product key features

  • Streamlined Two-Step Protocol - Directly labels antibodies or proteins in under two hours with a two-step process
  • Optimized for Small-Scale Labeling - Optimized for 100 µg of purified antibody or protein per reaction
  • High Fluorescence Sensitivity - PE-iFluor® 594 offers intense brightness, ideal for detecting low-abundance targets in flow cytometry and immunoassays
  • Enhanced Experimental Flexibility - Eliminates the need for secondary antibodies, providing greater flexibility for multicolor panel design

Product description

The Buccutite™ Rapid PE-iFluor® 594 Tandem Antibody Labeling Kit provides a streamlined approach for efficient, small-scale labeling of antibodies with PE-iFluor® 594. Compared to conventional methods such as SMCC crosslinking, Buccutite™ technology offers a more straightforward and reproducible solution. Using a simple two-step mixing protocol, antibodies or proteins can be conjugated with PE-iFluor® 594 in less than two hours. Each kit includes all reagents necessary for two labeling reactions, with Buccutite™ FOL-Activated PE-iFluor® 594 vials specifically formulated to label 100 µg of purified protein or antibody per reaction. Prior to labeling, stabilizing proteins (e.g., BSA) should be removed, and amine-rich buffers such as Tris should be avoided to prevent interference with the labeling chemistry.

PE-iFluor® 594 is a tandem fluorophore with excitation and emission maxima at ~565 nm and ~606 nm, respectively. Its high fluorescence intensity makes it particularly suitable for detecting low-abundance targets while minimizing spectral spillover and reducing compensation complexity. These properties make PE-iFluor® 594 an excellent choice for flow cytometry, spectral flow cytometry, and other immunoassays requiring high sensitivity. However, it is not recommended for applications where photostability is critical. This kit enables direct conjugation of primary antibodies, eliminating the need for secondary antibody labeling strategies. The resulting conjugates streamline workflows and facilitate the development of complex multicolor assays, enhancing experimental flexibility and reducing reagent complexity.

Example protocol

AT A GLANCE

Protocol Summary
  1. Add 5 µL Reaction Buffer (Component C) into antibody (100 µL)

  2. Add the antibody solution into Buccutite™ MTA vial (Component B)

  3. Incubate at room temperature for 30 minutes

  4. Mix with 50 µL Buccutite™ FOL-Activated PE-iFluor® 594 (Component A)

  5. Incubate at room temperature for 60 minutes

Important: Store the kit at 4 °C upon receipt. When stored correctly, the kit remains stable for six months. Alternatively, Component B can be stored at -20 °C. Avoid freezing Buccutite™ FOL-Activated PE-iFluor® 594 (Component A) and Reaction Buffer (Component C). Before use, warm all components to room temperature and briefly centrifuge the vials before opening. Prepare the necessary solutions immediately prior to starting the conjugation. The following SOP provides an example for labeling goat anti-mouse IgG antibody.

PREPARATION OF WORKING SOLUTION

Antibody Working Solution
  1. To label 100 µg of antibody (assuming a concentration of 1 mg/mL), mix 5 µL (5% of the total reaction volume) of Reaction Buffer (Component C) with 100 µL of the antibody solution.

    Note: If your antibody has a different concentration, adjust the volume to ensure approximately 100 µg of antibody is available for the labeling reaction.

    Note: The antibody should be dissolved in 1X phosphate buffered saline (PBS), pH 7.2-7.4; If the antibody is dissolved in glycine buffer, it must be dialyzed against 1X PBS, pH 7.2-7.4, or use ReadiUse™ 10KD Spin Filter (Cat. # 60502 from AAT Bioquest) to remove free amines or ammonium salts (such as ammonium sulfate and ammonium acetate) that are widely used for antibody precipitation.

    Note: Impure antibodies or antibodies stabilized with bovine serum albumin (BSA) or gelatin will not be labeled well.

    Note: The antibody –Buccutite™ MTA reaction efficiency is significantly reduced if the antibody concentration is less than 1 mg/mL. For optimal labeling efficiency the final antibody concentration range of 1-10 mg/mL is recommended.

SAMPLE EXPERIMENTAL PROTOCOL

Run Antibody-Buccutite™ MTA reaction
  1. Add the antibody working solution directly into the vial of Buccutite ™ MTA (Component B), and mix them well by repeatedly pipetting for a few times or vortex the vial for a few seconds.
  2. Keep the antibody- Buccutite ™ MTA reaction mixture at room temperature for 30 - 60 minutes.

    Note: The antibody-Buccutite™ MTA reaction mixture can be rotated or shaken for longer time if desired.

Make antibody-PE-iFluor® 594 Conjugation
  1. Make Buccutite™ FOL-Activated PE-iFluor® 594 solution by adding 50 µL ddH2O into the vial of Buccutite™ FOL-Activated PE-iFluor® 594 (Component A), mix well by repeatedly pipetting for a few times or vortex the vial for a few seconds.

  2. Mix whole vial of Buccutite™ FOL-Activated PE-iFluor® 594 solution into the antibody-Buccutite™ MTA solution, mix well and rotating the mixture for 1 hour at room temperature.

  3. The antibody-PE-iFluor® 594 conjugate is now ready to use.

    Note: For immediate use, the antibody-PE-iFluor® 594 conjugate need be diluted with the buffer of your choice.

Storage of Antibody-PE-iFluor® 594 Conjugate

The antibody conjugate should be stored at > 0.5 mg/mL in the presence of a carrier protein (e.g., 0.1% bovine serum albumin). The Antibody-PE-iFluor® 594 conjugate solution could be stored at 4 °C for two months without significant change when stored in the presence of 2 mM sodium azide and kept from light. For longer storage, the antibody-PE-iFluor® 594 conjugates could be lyophilized and stored at ≤ –20 °C.

Table 1. Available fluorophores at AAT Bioquest Buccutite™ Rapid Antibody Labelling Kits

Cat#LabelsEx (nm)Em (nm)
1325PerCP482677
1310PE565575
1318PE-Texas Red565600
1356PE-iFluor® 594565606
1322PE-Cy5565674
1316PE-Cy5.5565700
1358PE-iFluor® 710565710
1317PE-Cy7565780
1311APC651662
1320APC-Cy5.5651700
1319APC-iFluor® 700651713
1321APC-Cy7651780

 

Spectrum

References

View all 50 references: Citation Explorer
Investigation of the Impact of Single and Double Filtration Systems on Post-Consumer PE Film Waste.
Authors: Langwieser, Johanna and Fischer, Joerg
Journal: Polymers (2024)
Mitochondrial ROS Accumulation Contributes to Maternal Hypertension and Impaired Remodeling of Spiral Artery but Not IUGR in a Rat PE Model Caused by Maternal Glucocorticoid Exposure.
Authors: Long, Jing and Huang, Yan and Wang, Gang and Tang, Zhengshan and Shan, Yali and Shen, Shiping and Ni, Xin
Journal: Antioxidants (Basel, Switzerland) (2023)
Late stage specific Rv0109 (PE_PGRS1) protein of Mycobacterium tuberculosis induces mitochondria mediated macrophage apoptosis.
Authors: Priyanka, and Medha, and Bhatt, Parul and Joshi, Hemant and Sharma, Sadhna and Sharma, Monika
Journal: Microbial pathogenesis (2023): 106021
Quantitation of mHLA-DR and nCD64 by Flow Cytometry to Study Dysregulated Host Response: The Use of QuantiBRITE™ PE Beads and Its Stability.
Authors: Sanju, S and Jain, Paresh and Priya, Veeraraghavan Vishnu and Varma, Praveen K and Mony, Ullas
Journal: Applied biochemistry and biotechnology (2023): 5747-5752
Mycobacterium tuberculosis PE/PPE proteins enhance the production of reactive oxygen species and formation of neutrophil extracellular traps.
Authors: García-Bengoa, María and Meurer, Marita and Stehr, Matthias and Elamin, Ayssar A and Singh, Mahavir and Oehlmann, Wulf and Mörgelin, Matthias and von Köckritz-Blickwede, Maren
Journal: Frontiers in immunology (2023): 1206529
Page updated on December 17, 2024

Ordering information

Price
Unit size
Catalog Number1356
Quantity
Add to cart

Additional ordering information

Telephone1-800-990-8053
Fax1-800-609-2943
Emailsales@aatbio.com
InternationalSee distributors
Bulk requestInquire
Custom sizeInquire
Technical SupportContact us
Purchase orderSend to sales@aatbio.com
ShippingStandard overnight for United States, inquire for international
Request quotation

Spectral properties

Absorbance (nm)

566

Extinction coefficient (cm -1 M -1)

1960000

Excitation (nm)

565

Emission (nm)

606

Storage, safety and handling

H-phraseH303, H313, H333
Hazard symbolXN
Intended useResearch Use Only (RUO)
R-phraseR20, R21, R22
UNSPSC12171501

Components

AAT Bioquest offers the Buccutite™ rapid labeling kit to streamline PE tandem dye conjugation for antibodies and other proteins, including streptavidin and secondary reagents. This kit utilizes preactivated PE modified with Buccutite™ FOL, while your antibody or protein is modified with Buccutite™ MTA to produce MTA-modified proteins. The MTA-modified proteins react efficiently with FOL-modified PE, yielding the desired PE-antibody conjugate with significantly higher efficiency compared to traditional SMCC chemistry. Additionally, the reaction requires much lower biopolymer concentrations, enhancing efficiency and reducing material usage compared to SMCC-based methods.
AAT Bioquest offers the Buccutite™ rapid labeling kit to streamline PE tandem dye conjugation for antibodies and other proteins, including streptavidin and secondary reagents. This kit utilizes preactivated PE modified with Buccutite™ FOL, while your antibody or protein is modified with Buccutite™ MTA to produce MTA-modified proteins. The MTA-modified proteins react efficiently with FOL-modified PE, yielding the desired PE-antibody conjugate with significantly higher efficiency compared to traditional SMCC chemistry. Additionally, the reaction requires much lower biopolymer concentrations, enhancing efficiency and reducing material usage compared to SMCC-based methods.
AAT Bioquest offers the Buccutite™ rapid labeling kit to streamline PE tandem dye conjugation for antibodies and other proteins, including streptavidin and secondary reagents. This kit utilizes preactivated PE modified with Buccutite™ FOL, while your antibody or protein is modified with Buccutite™ MTA to produce MTA-modified proteins. The MTA-modified proteins react efficiently with FOL-modified PE, yielding the desired PE-antibody conjugate with significantly higher efficiency compared to traditional SMCC chemistry. Additionally, the reaction requires much lower biopolymer concentrations, enhancing efficiency and reducing material usage compared to SMCC-based methods.